We at Jainam Wealth recommend our Investors to “AVOID” to the Laurus Labs Ltd IPO. considering only ARVs, Hepatitis C & Oncology contributing 92% in FY16, top 5 customers contributing 68% of revenue, lower profitability margins and higher debt level.
Price Band Rs.426 - 428. Issue open on 06th December and close to 08th December. Market Lot 35 Shares.
blog comments powered by Disqus